Data as of Dec 26
| +0.70 / +1.10%|
The 16 analysts offering 12-month price forecasts for Charles River Laboratories International Inc have a median target of 65.00, with a high estimate of 75.00 and a low estimate of 53.00. The median estimate represents a +1.10% increase from the last price of 64.29.
The current consensus among 22 polled investment analysts is to Hold stock in Charles River Laboratories International Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.